Variable | Anti-thrombotic therapy Appro. Inappro. | COR (95%) | P-value | AOR (95%) | P-Value |
---|---|---|---|---|---|
Stroke | |||||
Yes | 33 6 | 3.46 (1.37–8.70) | 0.008 | 2.20 (0.56–8.70) | 0.25 |
No | 105 66 | ||||
Type of AF | |||||
Valvular | 58 16 | 3.09 (1.58–6.07) | 0.001 | 1.90 (0.80–4.80) | 0.14 |
Non-valvular | 81 55 | ||||
INR monitoring | |||||
vCan afford | 135 56 | 8.82 (2.80–27.72) | < 0.001 | 2.60 (1.10–6.10) | 0.001 |
Can’t afford | 4 15 | ||||
Heart failure | |||||
Yes | 124 66 | 0.8 (0.46–3.40) | 0.67 | ||
No | 14 6 | ||||
Hypertension | 0.8 (0.73–3.0) | ||||
Yes | 34 13 | 0.28 | |||
No | 104 59 | ||||
Thyrotoxicosis | |||||
Yes | 19 19 | 0.45 (0.22–0.90) | 0.026 | 0.80 (0.40–1.90) | 0.67 |
No | 119 53 | ||||
Age (years) | |||||
≥ 75 | 15 3 | 2.80 (0.78–10.03) | 0.13 | 2.20 (0.50–8.70) | 0.25 |
< 75 | 123 69 | ||||
Place of Residence | |||||
Urban | 68 34 | 1.08 (0.50–1.60) | 0.77 | ||
Rural | 70 38 | ||||
Formal education | |||||
Yes | 101 56 | 0.78 (0.60–2.50) | 0.41 | ||
No | 37 16 |